The global market for cytotoxicity assays is projected to register a Y-o-Y increase of 8.4% in 2022 to be valued at US$ 13,803.92 Million. As of 2021, cytotoxicity assays demand was valued at US$ 12,732.37 Million. During the 2022 to 2032 assessment period, the industry is likely to expand at a CAGR of 9.1%.
Report Attribute
Details
Estimated Base Year Value (2021)
US$ 12,732.37 Million
Expected Market Value (2022)
US$ 13,803.92 Million
Anticipated Forecast Value (2032)
US$ 32,978.94 Million
Projected Growth Rate (2022 to 2032)
9.1% CAGR
Cytotoxicity assays are primarily used to determine the effects of hazardous substances or physiological changes in cell type health. Cytotoxicity assays are the most commonly used tool for quantifying cell exposure to a cytotoxic stimulus.
Furthermore, cytotoxicity assays can be used to determine metabolic activity, cell growth inhibition, or cell division. The Cytotoxicity Assay also assists analysts and clinicians in determining the toxicity level of a specific medication or drugs to be used in the market.
Which are Some Prominent Drivers Spearheading Cytotoxicity Assays Market Growth?
One of the most important indicators used in the biological evaluation system is the cytotoxicity assay. Many experimental methods for evaluating cell cytotoxicity are constantly being developed and modernized as modern cell biology advances. Furthermore, some manufacturers have developed real-time and dynamic methods for quantifying cell morphology, proliferation, and differentiation in cytotoxicity assays.
Following this, other players are attempting to incorporate new real-time cell analysis system technologies into in vitro cytotoxicity tests of medical devices in order to meet the objectives of various tests and also to evaluate the accuracy of in vitro cytotoxicity assays.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Challenges Faced by the Cytotoxicity Assays Industry?
One significant disadvantage is the lack of uniform cytotoxicity test methods. Aside from that, there is no standardized protocol for performing cytotoxicity assays.
Why is North America emerging as an Opportunistic Cytotoxicity Assays Market?
During the forecast period, North America is expected to hold one of the largest shares of the global cytotoxicity assays market. The region's drivers include an increase in haematology and cell proliferation studies, oncology studies, and a variety of other cell-based studies.
Find your sweet spots for generating winning opportunities in this market.
How is Asia Pacific Contributing to Growth of the Cytotoxicity Assays Market?
According to Future Market Insights, Asia-Pacific countries, particularly India and China, are expected to grow at a significant rate over the assessment period. Factors such as a significant increase in the import of these assay kits from leading global manufacturers, as well as the presence of local manufacturers with R&D facilities in the region will drive the growth of the cytotoxicity assays market in this region. Japan, with its high R&D investments in medical devices and well-established healthcare infrastructure, will pave the way for the country's cytotoxicity assay market to grow.
Market Competition
Some of the key participants present in the global Cytotoxicity Assays market include F. Hoffman-La Roche AG Thermo Fisher Scientific, Inc, Danaher Corporation, Sakura Finetechnical Co., Ltd and Laboratory Corporation of America Holdings Merck KGaA among others.
Attributed to the presence of such high number of participants, the market is highly competitive.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Scope of Report
Report Attribute
Details
Growth Rate
CAGR of 9.1% from 2022 to 2032
Base Year for Estimation
2021
Historical Data
2015 to 2020
Forecast Period
2022 to 2032
Quantitative Units
Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
Product Type
Application
End User
Region
Regions Covered
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Countries Profiled
USA
Canada
Brazil
Mexico
Germany
UK
France
Spain
Italy
Nordics
BENELUX
Russia
Australia & New Zealand
China
Japan
South Korea
India
Thailand
Malaysia
Indonesia
GCC
South Africa
Key Companies Profiled
F. Hoffman-La Roche AG
Thermo Fisher Scientific Inc.
Danaher Corporation
Sakura Finetechnical Co., Ltd
Laboratory Corporation of America Holdings
Merck KGaA
Customization
Available Upon Request
Key Segments Profiled in the Cytotoxicity Assays Industry Survey
Cytotoxicity Assays for Academic & Research Laboratories
Cytotoxicity Assays for Pharma & Biotech Companies
Cytotoxicity Assays for Other End User Types
Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Frequently Asked Questions
What is the anticipated growth of the Cytotoxicity Assays market until 2032?
FMI projects the global Cytotoxicity Assays market to expand at a 9.1% value CAGR by 2032
Which region is forecast to be the most lucrative for Cytotoxicity Assays market growth?
Asia Pacific is expected to be the most opportunistic Cytotoxicity Assays market.
Which are some prominent Cytotoxicity Assays manufacturers?
F. Hoffman-La Roche AG Thermo Fisher Scientific, Inc, Danaher Corporation and Sakura Finetechnical Co., Ltd, are some prominent Cytotoxicity Assays manufacturers
